The landscape of dementia prognosis has evolved drastically with the advent of advanced biomarkers, including amyloid PET scans, tau imaging, and blood-based checks which will detect Alzheimer's pathology several years just before signs and symptoms arise. When these technological improvements symbolize remarkable progress in understanding neurodegenerative disorders, they've not dimi... https://bradh208fqa8.wikipresses.com/user